Subsequently, a significantly increased abundance of T helper 2 cells (Th2) and higher expression of PD‐L1 were observed in cervical cancer patients with lower expression of HOXA10 and HOXA11, indicative of the fact that HOXA10 and HOXA11 could be served as biomarkers of response to immunotherapy. The gene discussed is HOXA10; the disease is cervical carcinoma.